Reporting of adverse drug reactions by hospital pharmacists: Pilot scheme

British Medical Journal

Volumn 315, Issue 7107, 1997, Pages 519-

  Lee, Anne ^a   Nicholas Bateman, D ^a   Edwards, Clive ^a   Smith, James M ^a   Rawlins, Michael D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; DRUG MONITORING; HOSPITAL; HOSPITAL PERSONNEL; PHARMACIST; PRIORITY JOURNAL; RECORDING; UNITED KINGDOM;

EID: 8544284049     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7107.519     Document Type: Article

References (5)

1. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed. J R Coll Phys Lond 1995;29:41-9.
2. Committee on Safety of Medicines. Report of the Adverse Reactions Working Party, part II. London: Department of Health and Social Security, 1985.
3. Booth NJ, Luscombe DH, Smith CC, Veitch GBA, Grahame-Smith DG. Scheme to promote, monitor and assess the reporting of adverse drug reactions. Pharm J 1988;Nov 12:R3.
4. Winstanley PA, Irvin LE, Smith JC, Orme M L'E, Breckenrdige AM. Adverse drug reactions: a hospital pharmacy-based reporting scheme. Br J Clin Pharmacol 1989;28:113-6.
5. Committee on Safety of Medicines. Advice about adverse drug reaction reporting. Current Problems 1992;18(34):4.